Research Library

Drug policy has experienced an interesting shift recently. Along with legalization of medical and recreational marijuana, many states are also reducing penalties for nonviolent drug offenses and placing greater focus on treatment for drug users. The emphasis on treatment and rehabilitation for drug users is the result of many factors, including recognition that the drug war has not reduced drug use, a desire to reduce the prison population and save money, and a surge in the rate of overdoses from opioid and heroin use. What remains to be seen is whether the current popularity of drug treatment will become a more permanent feature of drug policy. In this Baker Institute Viewpoints series, five experts on drug policy examine the question, “Is the current emphasis on treatment in drug policy a short-term trend or is it here to stay?”

Stem cells from umbilical cord blood (CB) can be used to treat over 80 different diseases, including many types of leukemia, lymphoma and inherited immune system disorders. Extensive storage facilities in the United States and around the world collect, test and freeze CB for later use in medical procedures. However, the divide between two different banking models — public versus private — presents policy challenges. This policy report examines the difference between public and private cord blood banks and offers recommendations for US policymakers to improve cord blood banking and ensure high quality standards.

Many contemporary medical ethicists dismiss the centuries-old Hippocratic Oath as outdated because of the enormous scientific, social, economic, and political changes since Hippocrates' time. Health policy scholar Hagop Kantarjian makes a case for its relevance.

The United States should assign a particularly high priority on science and technology over the next four years, especially for federal support of research.

An introduction to stem cells and their potential uses.

A Civic Scientist Précis on Stephen Minger, Ph.D.

An introduction to stem cells, their potential uses, and domestic and international policies regarding stem cells.

A discussion of induced pluripotent stem (iPS) cells, recently developed stem-like cells that are being considered for new research.